Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
gene therapy
glaxosmithkline
3
×
life sciences
merck
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adverum biotechnologies
alzheimer's disease
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
diagnostics
drug prices
generic drugs
What
bio
drug
3
×
roundup
acquisitions
advanced
albert
approval
arrival
award
biggest
biogen’s
biopharmaceutical
bourla
cancer
ceo
companies
company
convo
crispr
data
death
decades
dems
earlier
failures
future
given
immunotherapy
imports
littered
longer
lung
maker
maps
measured
medical
nash
new
news
patients
Language
unknown
unset
Current search:
glaxosmithkline
×
national
×
drug
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More